【黑石拟收购日本临床研究机构CMIC六成权益 或涉及数亿美元】全球最大另类资产管理人黑石正收购一家专注于帮助制药公司在日本进行临床试验的公司CMIC Co.,反映其对日本老龄化人口健康需求的兴趣日益增加。据悉,黑石同意收购CMIC Co. 60%股权,惟未有透露具体金额,仅指交易的价值可达数亿美元。黑石日本私募股权主管Atsuhiko Sakamoto曾在访问中表示,日本的临床试验过程效率颇低,对比其他市场需时非常长。它们目前将简化过程,可以更快介绍新药到日本,而黑石可以从中作出贡献。

金融界
03 Mar
全球最大另类资产管理人黑石正收购一家专注于帮助制药公司在日本进行临床试验的公司CMIC Co.,反映其对日本老龄化人口健康需求的兴趣日益增加。据悉,黑石同意收购CMIC Co. 60%股权,惟未有透露具体金额,仅指交易的价值可达数亿美元。黑石日本私募股权主管Atsuhiko Sakamoto曾在访问中表示,日本的临床试验过程效率颇低,对比其他市场需时非常长。它们目前将简化过程,可以更快介绍新药到日本,而黑石可以从中作出贡献。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10